News

Movetis starts Phase III clinical trial with prucalopride in patients with opioid-induced constipation (OIC)
New trial marks first step in Movetis’ label expansion strategy for Resolor® Dutch Version Read more >
19/05/2010
|
Investors
|
English
application/pdf icon
Movetis starts clinical trial with prucalopride in OIC
Trading Update 1stQ/2010 - Movetis advances business plan while controlling expenditure
Movetis advances business plan while controlling expenditureMarket introduction of Resolor highlight of first quarter Turnhout ... Read more >
03/05/2010
|
Investors
|
English
application/pdf icon
Movetis trading update 1stQ 2010
Movetis holds Annual and Extraordinary Shareholders Meeting on May 3, 2010
08/04/2010
|
Investors
Read more >
Movetis announces that Resolor® is now available in the UK
24/03/2010
|
Investors
Read more >
Movetis announces 2009 full year results
26/02/2010
|
Investors
Read more >
Disclosure in accordance with the Act of 2 May 2007
12/02/2010
|
Investors
Read more >
Disclosure in accordance with the Act of 2 May 2007
05/02/2010
|
Investors
Read more >
Movetis launches Resolor® in Germany
27/01/2010
|
Investors
Read more >
Movetis receives positive ruling regarding patent income deduction. Effective tax rate will be reduced significantly
13/01/2010
|
Investors
Read more >

Go to archive >

Print

 MailMail